Trial of VLTS-589 in Subjects With Intermittent Claudication

Summary

The purpose of this study is to evaluate the safety and tolerability of VLTS-589 compared with placebo, administered bilaterally to the lower extremities, in subjects with intermittent claudication and to determine the effect of VLTS-589 in peak walking time (PWT) for subjects receiving VLTS-589 compared with subjects receiving placebo.

Timeline

Start

2003-06

Primary completion

—

Completion

2005-06

Drugs

Indications